FRANZA, ANDREA
FRANZA, ANDREA
Universita' degli Studi di MILANO
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study
2025 S. Rota, S. Buriolla, A. Franza, S. Cavalieri, C. Bergamini, S. Alfieri, I. Nuzzolese, E. Colombo, A. Ottini, B. Lombardi Stocchetti, G. Massa, A. Caraceni, L. Licitra, C. Resteghini
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial
2024 F. Ligorio, R. Lobefaro, G. Fucà, L. Provenzano, L. Zanenga, V. Nasca, C. Sposetti, G. Salvadori, A. Ficchì, A. Franza, A. Martinetti, E. Sottotetti, B. Formisano, C. Depretto, G. Scaperrotta, A. Belfiore, A. Vingiani, C. Ferraris, G. Pruneri, F. de Braud, C. Vernieri
Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of art
2024 A. Franza, E. Gusmaroli, C. Fabbroni, R. Vigorito, S. Pasquali, P.G. Casali, R.G. Sanfilippo
New targeted therapies in liposarcoma: state of art and future perspectives
2024 A. Franza, C. Fabbroni, S. Pasquali, P.G. Casali, R. Sanfilippo
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study
2022 M. Niger, F. Nichetti, A. Casadei-Gardini, M.D. Rizzato, C. Pircher, M. Bini, A. Franza, M. Rimini, V. Burgio, C. Sposetti, L. Fornaro, I.G. Rapposelli, F.E. D'Amico, G. Aprile, C. Vivaldi, G.L. Frassineti, M. Milione, G. Leoncini, A. Cappetta, E. Vasile, M. Fassan, F. Morano, F. Perrone, E. Tamborini, G. Pruneri, S. Lonardi, V. Mazzaferro, F. Pietrantonio, M. Di Bartolomeo, F. de Braud
Erdafitinib in locally advanced/metastatic urothelial carcinoma with certain FGFR genetic alterations
2022 A. Franza, M. Pirovano, P. Giannatempo, L. Cosmai